ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Mitsubishi Pharma Corporation

Include trials that are no longer recruiting patients.

3 studies were found.
1.TerminatedEfficacy/safety of ecraprost in lipid emulsion for treatment of critical leg ischemia due to peripheral arterial disease
Condition: Critical Limb Ischemia due to peripheral arterial disease
2.RecruitingEfficacy/safety of ecraprost in lipid emulsion for treatment of critical leg ischemia due to peripheral arterial disease
Condition: Critical Limb Ischemia due to peripheral arterial disease
3.RecruitingMCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction Patients
Condition: Myocardial Infarction

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act